Both the glucose-degradation products and advanced glycation end-products have been reported to activate transforming growth factor (TGF)-β1 signaling in the peritoneal membrane, thus promoting peritoneal fibrosis [14,15,17–20]. The gene discussed is TGFB1; the disease is Peritoneal Fibrosis.